 |
Profile
We are particularly interested in doing cases where there is injustice.
Our recent experience in commencing these types of cases is as follows: In 2005, we issued the Air France class action, when a plane careened off the runway at Pearson International Airport and burst into flames. In 2005, we issued the Seven Oaks and Community Legionnaires case, where people got sick and many died as a result of bacteria eminating from the cooling tower. In 2005, we issued the Depo-Provera class action where Pfizer finally came forward and said the injectable contraceptive, once hailed by the company as more effective than the pill and other forms of both control, is causing bone mineral density loss that may not be reversible and reduce peak bone mass and increase the risk of osteoporotic fracture. We also issued a case against Sun Wah Trading Inc. in relation to the outbreak of Salmonella, affecting hundreds of people.
In 2006, we issued the Hepatitis B & C class action, now certified, against Scarborough Hospital relating to infections in the dialysis unit. We also issued, among others, Tequin, when Health Canada advised diabetic patients, as a precaution, not to use the antibiotic due to concerns about blood glucose disorders. Tequin, now withdrawn, was used to treat respiratory infections, urinary tract and bladder infections, and sexually transmitted diseases. People taking Tequin showed more than a four-fold increase in the risk of being treated in hospital for low blood sugar compared to people who were on an older class of antibiotics. Studies showed nearly 17 times more risk of developing high blood sugar.
Not only health related class actions, in 2005 we issued the Templeton Fund class action, in which frequent trading market timing and management fees had impaired performance of the fund to the detrimnet of its investors and where the OSC had conducted a probe. In 2006, we also issued a case against Sony, relating to the use of digital rights management and copyright protection, which has settled. In 2007 and 2008, we issued a number of commercial class actions, relating to consumer protection legislation, including Mister Transmission and a case against car manufacturers.
In 2003, we issued the class action involving the Loblaws Hepatitis A incident, in which an employee handled produce while infected and at the risk of infecting consumers. We issued the Rezulin diabetes drug class action against Pfizer in 2002, when the drug in clinical trials caused liver damage and death. This is the only Rezulin class action issued in Canada.
We willingly take on cases where the issues seem to indicate negligent conduct affecting many people, for example in Seven Oaks Home for the Aged and the community where so many people recently suffered and are suffering and the response in regard to diagnosis and prevention has been far too slow, in Air France Flight 358 where over 300 people faced terrible danger and suffering, in the Loblaws case where more than 18,000 people had vaccinations to thwart Hep A, and for Rezulin where many people were exposed to harm from a drug in clinical trials, and for Depo-Provera where Pfizer did not come forward immediately after studies showed serious BMD loss.
Over the years, we have established and cultivated close working relationships with a number of firms specializing in class actions. We have also worked as co-counsel on files.
Together, we have additional specialty including a Ph.D. in Health Care, which is accessible online, an executive MBA degree, and Canadian and U.S. law degrees, all of which results in the ability to strengthen cases and strategically plan how to move every case forward to the benefit of clients and Class Members.